F
Fulvia Daffara
Researcher at University of Turin
Publications - 39
Citations - 3075
Fulvia Daffara is an academic researcher from University of Turin. The author has contributed to research in topics: Mitotane & Adrenocortical carcinoma. The author has an hindex of 26, co-authored 39 publications receiving 2739 citations.
Papers
More filters
Journal ArticleDOI
Adjuvant mitotane treatment for adrenocortical carcinoma.
Massimo Terzolo,Alberto Angeli,Martin Fassnacht,Fulvia Daffara,Libuse Tauchmanovà,Pier Antonio Conton,R. Rossetto,Lisa Buci,Paola Sperone,Erika Grossrubatscher,Giuseppe Reimondo,Enrico Bollito,Mauro Papotti,Wolfgang Saeger,Stefanie Hahner,Ann Cathrin Koschker,Emanuela Arvat,Bruno Ambrosi,Paola Loli,Gaetano Lombardi,Massimo Mannelli,Paolo Bruzzi,Franco Mantero,Bruno Allolio,Luigi Dogliotti,Alfredo Berruti +25 more
TL;DR: Adjuvant mitotane treatment had a significant advantage for recurrence-free survival in patients with radically resected adrenocortical carcinoma, and temporary dose reduction was needed in 13% of patients.
Journal ArticleDOI
Adrenal incidentaloma: a new cause of the metabolic syndrome?
Massimo Terzolo,Anna Pia,A. Alì,Giangiacomo Osella,Giuseppe Reimondo,Silvia Bovio,Fulvia Daffara,Massimo Procopio,Piero Paccotti,Giorgio Borretta,Alberto Angeli +10 more
TL;DR: Many patients with incidental adrenal adenoma display altered glucose tolerance, that may be explained by reduced insulin sensitivity, and increased blood pressure levels in comparison with carefully age- and BMI-matched controls.
Journal ArticleDOI
Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection
Felix Beuschlein,Jens Weigel,Wolfgang Saeger,Matthias Kroiss,Vanessa Wild,Fulvia Daffara,R. Libe,Arianna Ardito,Abir Al Ghuzlan,Marcus Quinkler,Andrea Oßwald,Cristina L. Ronchi,Ronald R. de Krijger,Richard A Feelders,Jens Waldmann,Holger S. Willenberg,Timo Deutschbein,Anthony Stell,Martin Reincke,Mauro Papotti,Eric Baudin,Frédérique Tissier,Harm R. Haak,Paola Loli,Massimo Terzolo,Bruno Allolio,Hans Müller,Martin Fassnacht +27 more
TL;DR: This largest study on prognostic markers in localized ACC identified Ki67 as the single most important factor predicting recurrence in patients following R0 resection and should be introduced as standard grading in all pathology reports of patients with ACC.
Journal ArticleDOI
Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer
Francesco Porpiglia,Cristian Fiori,Fulvia Daffara,Barbara Zaggia,Enrico Bollito,Marco Volante,Alfredo Berruti,Massimo Terzolo +7 more
TL;DR: There is interesting evidence that OA and LA may be comparable in terms of recurrence-free survival for patients with stage I and II ACC when the principles of surgical oncology are respected.
Journal ArticleDOI
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.
I G C Hermsen,Martin Fassnacht,Massimo Terzolo,S. Houterman,Jan den Hartigh,Sophie Leboulleux,Fulvia Daffara,Alfredo Berruti,Rita Chadarevian,Martin Schlumberger,Bruno Allolio,Harm R. Haak,Eric Baudin +12 more
TL;DR: The data confirm the value of o,p'DDD plasma monitoring as well as targeting the 14 mg/liter cutoff level in the therapeutic management of ACC patients and suggest additional benefit of higher levels of o',p' DDD and combined measurement of o'DDE and o, p'DDA.